[Contraception, therapeutic abortion, and pulmonary arterial hypertension].

Abstract : Despite therapeutic advances, maternal mortality is high in pulmonary arterial hypertension (PAH). PAH treatment may interfere with the proposed method of contraception. Moreover, some treatments (endothelin receptor antagonists, anti-vitamin K) are teratogenic. If pregnancy is strictly not recommended in PAH, few specific contraceptive guidelines are available. The contraceptive method must be discussed on a case by case basis with the patient, the reference team for PAH, and the gynecology department.The advantages of the intrauterine device (IUD) with progesterone (reliability, simplicity, compliance, few contraindications and interactions, possibility of use in the nulliparous patient, reimbursement by the healthcare system) make it a good contraceptive choice in these circumstances. Therapeutic abortion is a situation of contraceptive failure, it must always be performed in hospitals. It must lead to effective contraceptive advice.
Type de document :
Article dans une revue
La Presse medicale, Paris, Masson et Cie, 2010, 39 Suppl 1, pp.1S46-50. 〈10.1016/S0755-4982(10)70007-5〉
Liste complète des métadonnées

Contributeur : Ghislaine Calvez <>
Soumis le : mardi 14 janvier 2014 - 09:23:28
Dernière modification le : mercredi 10 janvier 2018 - 14:42:02




Irène Frachon, Stéphanie Pozzi Gaudin, Catherine Jezequel, Xavier Jaïs, Christophe Gut-Gobert, et al.. [Contraception, therapeutic abortion, and pulmonary arterial hypertension].. La Presse medicale, Paris, Masson et Cie, 2010, 39 Suppl 1, pp.1S46-50. 〈10.1016/S0755-4982(10)70007-5〉. 〈hal-00929840〉



Consultations de la notice